BridgeMD
New treatment option for Cervical Cancer
Official title Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier
ClinicalTrials.gov ID: NCT04859530
What this study is testing
- What it's testing
- Cervical cancer remains a major public health challenge in low- and middle-income countries (LMICs) due to financial and logistical issues. The World Health Organization (WHO) recommendation for cervical cancer screening in LMICs includes Human Papillomavirus (HPV) testing as primary screening followed by visual inspection with acetic acid (VIA) and treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 49, women only. Healthy volunteers may be eligible.
You may be able to join if
- Free and informed consent to take part in the study on a voluntary basis
You likely can't join if
- No initiation of sexual intercourse
- Pregnancy at the screening consultation
- Any condition altering the cervix visualization at the screening consultation (e.g. heavy vaginal bleeding)
- History of anogenital cancer or known anogenital cancer at the screening consultation
- Previous hysterectomy
- Not sufficiently healthy to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Dschang, Menoua, Cameroon
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 30 years to 49 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dschang, Menoua, Cameroon. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.